MP52-14 FOLLICLE-STIMULATING HORMONE THERAPY AFTER MICROSURGICAL VASOEPIDIDYMOSTOMY

Follicle-stimulating hormone

Bioactive Follicle-Stimulating Hormone

Specific and sensitive in vitro bioassays suitable for measurement of follicle-stimulating hormone (FSH) in small quantities of serum and urine have recently been validated. Comparisons of bioassay (B-FSH) potencies with immunoassay (I-FSH) estimates and chromatofocusing patterns have facilitated new discoveries regarding the regulation of FSH biosynthesis, storage, secretion, serum concentrati...

Microsurgical vasoepididymostomy for obstructive azoospermia

Infertility is defined as the inability to conceive after 1 year of regular unprotected sexual intercourse. About 15% of couples are affected. Male factors account for about 50% of couples with infertility.1 Approximately 10 to 15% of infertile men suffer from azoospermia—complete absence of sperms in the ejaculate. Among these azoospermic patients, approximately 40% have complete obstruction i...

Inhibin B plasma concentrations in oligozoospermic subjects before and after therapy with follicle stimulating hormone.

The aim of this study was to investigate inhibin B and follicle stimulating hormone (FSH) secretion in a large group of oligozoospermic subjects affected by different degrees of testicular damage, before and after FSH treatment. A total of 135 oligozoospermic subjects (sperm count < 20 x 10(6)/ml) were evaluated for seminal parameters and FSH, luteinizing hormone (LH), testosterone and inhibin ...

The Correlations of Anti-Mullerian Hormone, Follicle-Stimulating Hormone and Antral Follicle Count in Different Age Groups of Infertile Women